Litcius/Paper detail

Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study

Siddharth Kunte, Lisa Rybicki, Auro Viswabandya, Roni Tamari, Asad Bashey, Alla Keyzner, Madiha Iqbal, Michael R. Grunwald, Bhagirathbhai Dholaria, Hany Elmariah, Michael Ozga, Anurag K. Singh, Sameem Abedin, Amy E. DeZern, Richard J. Jones, Vikas Gupta, Aaron T. Gerds, Tania Jain

2021Leukemia41 citationsDOIOpen Access PDF

Topics & Concepts

MedicineMyelofibrosisCumulative incidenceCyclophosphamideInternal medicineTransplantationGastroenterologyBone marrowIncidence (geometry)SurgerySplenectomyGraft-versus-host diseaseBusulfanTotal body irradiationChemotherapySpleenPhysicsOpticsMyeloproliferative Neoplasms: Diagnosis and TreatmentMultiple Myeloma Research and TreatmentsChronic Myeloid Leukemia Treatments
Allogeneic blood or marrow transplantation with haploidentical donor and post-transplantation cyclophosphamide in patients with myelofibrosis: a multicenter study | Litcius